Agarwal Arjun sold ORKA
March 16, 2026 · Form 4 insider transaction
Agarwal Arjun sold 395 shares of Oruka Therapeutics, Inc. at $41.30 per share, a transaction worth $16.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
395
Price
$41.30
Total value
$16.3K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 16, 2026
Filing dateMarch 17, 2026
Shares owned after18,863
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.